{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T17:33:29Z","timestamp":1791048809573,"version":"4.1.0"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"19","content-domain":{"domain":["neurology.org"],"crossmark-restriction":true},"short-container-title":["Neurology"],"published-print":{"date-parts":[[2010,5,11]]},"DOI":"10.1212\/wnl.0b013e3181dd43bf","type":"journal-article","created":{"date-parts":[[2010,5,10]],"date-time":"2010-05-10T20:24:55Z","timestamp":1273523095000},"page":"1517-1523","update-policy":"https:\/\/doi.org\/10.1212\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":112,"title":["Ephedrine treatment in congenital myasthenic syndrome due to mutations in\n            <i>DOK7<\/i>"],"prefix":"10.1212","volume":"74","author":[{"given":"D.","family":"Lashley","sequence":"first","affiliation":[{"name":"From the Neuroscience Group (D.L., D.B.), Weatherall Institute of Molecular Medicine, The John Radcliffe, Oxford; Departments of Neurology (D.L., J.P.) and Paediatric Neurology (S.J.), John Radcliffe Hospital, Oxford; and Dubowitz Neuromuscular Centre (S.R.), Institute of Child Health &amp; Great Ormond Street Hospital, London, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Palace","sequence":"additional","affiliation":[{"name":"From the Neuroscience Group (D.L., D.B.), Weatherall Institute of Molecular Medicine, The John Radcliffe, Oxford; Departments of Neurology (D.L., J.P.) and Paediatric Neurology (S.J.), John Radcliffe Hospital, Oxford; and Dubowitz Neuromuscular Centre (S.R.), Institute of Child Health &amp; Great Ormond Street Hospital, London, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Jayawant","sequence":"additional","affiliation":[{"name":"From the Neuroscience Group (D.L., D.B.), Weatherall Institute of Molecular Medicine, The John Radcliffe, Oxford; Departments of Neurology (D.L., J.P.) and Paediatric Neurology (S.J.), John Radcliffe Hospital, Oxford; and Dubowitz Neuromuscular Centre (S.R.), Institute of Child Health &amp; Great Ormond Street Hospital, London, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Robb","sequence":"additional","affiliation":[{"name":"From the Neuroscience Group (D.L., D.B.), Weatherall Institute of Molecular Medicine, The John Radcliffe, Oxford; Departments of Neurology (D.L., J.P.) and Paediatric Neurology (S.J.), John Radcliffe Hospital, Oxford; and Dubowitz Neuromuscular Centre (S.R.), Institute of Child Health &amp; Great Ormond Street Hospital, London, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Beeson","sequence":"additional","affiliation":[{"name":"From the Neuroscience Group (D.L., D.B.), Weatherall Institute of Molecular Medicine, The John Radcliffe, Oxford; Departments of Neurology (D.L., J.P.) and Paediatric Neurology (S.J.), John Radcliffe Hospital, Oxford; and Dubowitz Neuromuscular Centre (S.R.), Institute of Child Health &amp; Great Ormond Street Hospital, London, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"crossref","unstructured":"Engel AG Shen XM Selcen D Sine SM. What have we learned from the congenital myasthenic syndromes? J Mol Neurosci Epub 2009.","DOI":"10.1007\/s12031-009-9229-0"},{"key":"e_1_3_2_3_2","first-page":"2","volume":"201","year":"2008","unstructured":"Palace J, Beeson D. The congenital myasthenic syndromes. J Neuroimmunol 2008;201\u2013202:2\u20135.","journal-title":"Neuroimmunol"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1130837"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awm068"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awm072"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.21408"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.20944"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1127142"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.2008.065425"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awl200"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1930.27120410003009c"},{"key":"e_1_3_2_13_2","first-page":"1401","volume":"100","year":"1933","unstructured":"Edgeworth H. The effect of ephedrine in the treatment of myasthenia gravis. JAMA 1933;100:1401.","journal-title":"JAMA"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0301-0082(00)00055-1"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(93)90025-I"},{"key":"e_1_3_2_16_2","first-page":"346","volume":"18","year":"1996","unstructured":"Milone M, Engel AG. Block of endplate acetylcholine receptor channel by the sympathomimetic agents ephedrine, pseudoephedrine and albuterol. Brain Res 1996;18:346\u2013352.","journal-title":"Brain Res"},{"key":"e_1_3_2_17_2","first-page":"186","volume":"4","year":"2007","unstructured":"Engel AG. The therapy of congenital myasthenic syndromes. Neurotherapeutics 2007;4:186\u2013197.","journal-title":"Neurotherapeutics"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.55.1.16"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00028.2007"},{"key":"e_1_3_2_20_2","first-page":"6","volume":"201","year":"2008","unstructured":"Kinali M, Beeson D, Pitt MC, et al. Congenital myasthenic syndromes in childhood: diagnostic and management challenges. J Neuroimmunol 2008;201\u2013202:6\u201312.","journal-title":"Neuroimmunol"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000167132.35865.31"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awm325"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2009.06.015"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1038\/nn1071"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1038\/nn0703-653"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-006-6081-z"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M708607200"},{"key":"e_1_3_2_28_2","first-page":"25","volume":"27","year":"2008","unstructured":"Yamanashi Y, Higuchi O, Beeson D. Dok7\/MuSK signaling and a congenital myasthenic syndrome. Acta Myologica 2008;27:25\u201329.","journal-title":"Acta Myologica"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2009.09.008"}],"container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/pdfdirect\/10.1212\/WNL.0b013e3181dd43bf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T12:55:16Z","timestamp":1711630516000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.0b013e3181dd43bf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5,11]]},"references-count":28,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2010,5,11]]}},"alternative-id":["10.1212\/WNL.0b013e3181dd43bf"],"URL":"https:\/\/doi.org\/10.1212\/wnl.0b013e3181dd43bf","relation":{},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,5,11]]}}}